BEAM•benzinga•March 10, 2025 at 10:04 AM

Beam Therapeutics Priced Underwritten Offering Of 16.15M Shares At $28.48 Per Share, And Pre-funded Warrants To Purchase 1.40M Shares At $28.47 Per Pre-funded Warrant, With Gross Proceeds Of Of Approximately $500M

No summary available.

Read the full article from the original source for complete details and context.

Article published on March 10, 2025 by benzinga